RECRUITING

Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)

Talk to us

Conditions

Cancer PainOncology PainReiki

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to investigate the delivery of Reiki to integrative oncology patients and assess its potential for improving cancer-related symptoms in this population.

Official Title

Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)

Quick Facts

Study Start:2024-08-07
Study Completion:2025-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06354049

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 89 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 - 89.
  2. * Neoplasm diagnosis (i.e., ICD-10 C00 - D49) confirmed in electronic health record (EHR)/Caisis
  3. * Receiving care at a UH Connor Whole Health Integrative Oncology Clinic.
  4. * Reporting at least three ESAS symptoms ≥4/10 at baseline screening including fatigue and ≥2 other symptoms on the 9-item questionnaire.
  5. * Able to speak and understand English.
  6. * Has an email address, and access to a computer with internet and/or a mobile device with a functioning data plan
  1. * Significant cognitive impairment that has not been corrected.
  2. * Significant visual impairment that has not been corrected.
  3. * Unable to provide informed consent.
  4. * Active psychosis.
  5. * Pregnancy.
  6. * Metastatic disease.
  7. * Reiki therapy within 3 months of study enrollment
  8. * Active immunotherapy, chemotherapy, or radiation treatment, or completed within 3 months before study start. Aromatase inhibitors and tamoxifen are exceptions.

Contacts and Locations

Study Contact

Santosh Rao, MD
CONTACT
858-945-2446
Santosh.Rao@UHhospitals.org

Principal Investigator

Santosh Rao, MD
PRINCIPAL_INVESTIGATOR
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center

Study Locations (Sites)

University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106
United States

Collaborators and Investigators

Sponsor: Case Comprehensive Cancer Center

  • Santosh Rao, MD, PRINCIPAL_INVESTIGATOR, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-07
Study Completion Date2025-03-31

Study Record Updates

Study Start Date2024-08-07
Study Completion Date2025-03-31

Terms related to this study

Keywords Provided by Researchers

  • Reiki

Additional Relevant MeSH Terms

  • Cancer Pain
  • Oncology Pain